Cases & Deals

Japanese pharmaceutical company seeks advice regarding collaboration agreement

Clients Japanese pharmaceutical company

Jones Day successfully advised a Japanese pharmaceutical company with respect to a potential dispute in connection with a collaboration agreement entered into with certain pharmaceutical companies and concerning a medicinal product approved by the United States Food and Drug Administration for the treatment of cancer.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.